Drugs & Cosmetics
-
Franchise India Bureau Jul 30 2018 - 1 min readDrug Company Wockhardt has built its maiden facility in the Middle East in Dubai for the manufacture of new chemical entities (NCEs) to supply to the global markets. Spread over 10,000 sq meters, the facility is self-sufficient for handling warehousing, manufacturing operations, product testing and product stability, Wockhardt said in a statement. "With the new ...
-
Franchise India Bureau Jul 25 2018 - 1 min readSun Pharmaceutical Industries today said one of its wholly owned subsidiaries has launched generic metformin hydrochloride extended release tablets, used for glycemic control, in the US market. The tablets have been launched in the strengths of 500 mg and 1000 mg, it said in a filing to BSE. The tablets are generic versions of Santarus ...
-
Franchise India Bureau Jul 20 2018 - 1 min readDrug firm Alembic Pharmaceuticals today said it has received establishment inspection report (EIR) from the US health regulator for its Karakhadi facility in Gujarat. The company has received EIR from the United States Food and Drug Administration (USFDA) for the inspection carried out at the active pharmaceutical ingredient facility at Karakhadi from May 14-18, 2018, ...
-
Franchise India Bureau Jul 13 2018 - 3 min readGerman pharma major Boehringer Ingelheim clocked a 43.7 per cent compounded annual growth rate (CAGR) in the domestic anti-diabetes therapy segment in the past three years, catapulting to the eighth spot from the 15th position in 2016. The company’s new launches and marketing tie-ups helped propel growth. Boehringer saw the highest growth among leading diabetes ...
-
Franchise India Bureau Jul 12 2018 - 1 min readCipla Ltd, India’s second-largest drugmaker by market value, has agreed to acquire South Africa’s Mirren (Pty) Ltd to strengthen its foothold in the African nation. The Indian company will pay 450 million South African rand (Rs 228 crore or $33 million) for Mirren in cash, it said in a stock-exchange filing. Paul Miller, CEO at ...